Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Miranda M.W. van Dongen"'
Autor:
René Bernards, Roderick L. Beijersbergen, Hendrik J. Kuiken, Miranda M.W. van Dongen, Armida W.M. Fabius, Jasper Mullenders
The transforming growth factor β (TGFβ) pathway orchestrates an extensive transcriptional program that is important for many processes in the cell. For example, TGFβ regulates cell cycle, migration, and epithelial-to-mesenchymal transition. The TG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::956991dda469f524013b36fbc6eebf4a
https://doi.org/10.1158/1541-7786.c.6541974
https://doi.org/10.1158/1541-7786.c.6541974
Autor:
René Bernards, Roderick L. Beijersbergen, Hendrik J. Kuiken, Miranda M.W. van Dongen, Armida W.M. Fabius, Jasper Mullenders
Supplementary Data from Interleukin-1R–Associated Kinase 2 Is a Novel Modulator of the Transforming Growth Factor β Signaling Cascade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27d28e677f33b532355515d4fa9ab50a
https://doi.org/10.1158/1541-7786.22518528
https://doi.org/10.1158/1541-7786.22518528
Autor:
René Bernards, Christian Klein, Georg Tiefenthaler, Roderick L. Beijersbergen, Rogier van Willigen, Ulrike Reiff, Miranda M.W. van Dongen, Wolfgang von der Saal, Jasper Mullenders
Purpose: A major impediment in the optimal selection of cancer patients for the most effective therapy is the lack of suitable biomarkers that foretell the response of a patient to a given drug. In the present study, we have used large-scale RNA inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c89c7c4affbc1ac1861b083a6528b07
https://doi.org/10.1158/1078-0432.c.6517966.v1
https://doi.org/10.1158/1078-0432.c.6517966.v1
Autor:
René Bernards, Christian Klein, Georg Tiefenthaler, Roderick L. Beijersbergen, Rogier van Willigen, Ulrike Reiff, Miranda M.W. van Dongen, Wolfgang von der Saal, Jasper Mullenders
Supplementary Data from Candidate Biomarkers of Response to an Experimental Cancer Drug Identified through a Large-scale RNA Interference Genetic Screen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e57bc8046a5f38acf34ae3277614c0
https://doi.org/10.1158/1078-0432.22440667
https://doi.org/10.1158/1078-0432.22440667
Autor:
Remond J.A. Fijneman, Helma van Grevenstein, Victor E. Velculescu, Linda J.W. Bosch, Karlijn L. van Rooijen, Miriam Koopman, Veerle M.H. Coupé, John K. Simmons, Daan van den Broek, Geraldine R. Vink, Amy Greer, Suzanna J. Schraa, Miranda M.W. van Dongen, Sjoerd G. Elias, Jillian Phallen, Samuel V. Angiuoli, Helena M. Verkooijen, Carmen Rubio Alarcón, Dave E. W. van der Kruijssen, Gerrit A. Meijer
Publikováno v:
Cancer Research. 81:CT251-CT251
Background Accurate detection of patients with minimal residual disease (MRD) after resection of localized colon cancer remains an unmet clinical need as these patients might benefit from adjuvant chemotherapy (ACT). For stage II colon cancer, ACT is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41e88a9f2765a75544ca1b467df64b95
https://doi.org/10.1158/1538-7445.am2021-ct251
https://doi.org/10.1158/1538-7445.am2021-ct251
Autor:
Wolfgang von der Saal, Rogier van Willigen, Ulrike Reiff, René Bernards, Miranda M.W. van Dongen, Jasper Mullenders, Georg Tiefenthaler, Roderick L. Beijersbergen, Christian Klein
Publikováno v:
Clinical Cancer Research. 15:5811-5819
Purpose: A major impediment in the optimal selection of cancer patients for the most effective therapy is the lack of suitable biomarkers that foretell the response of a patient to a given drug. In the present study, we have used large-scale RNA inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b701d704dcb008ac4509721a8d72ca1
https://doi.org/10.1158/1078-0432.ccr-09-0261
https://doi.org/10.1158/1078-0432.ccr-09-0261
Autor:
René Bernards, E. Marielle Hijmans, Miranda M.W. van Dongen, Claude Sardet, Sebastian M.B. Nijman, Selma El Messaoudi
Publikováno v:
Journal of biological chemistry, 281(31), 21582. American Society for Biochemistry and Molecular Biology
The helix-loop-helix transcription factor TFE3 has been suggested to play a role in the control of cell growth by acting as a binding partner of transcriptional regulators such as E2F3, SMAD3, and LEF-1 (1–4). Furthermore, translocations/TFE3 fusio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a6ef735c107f3f0291d1d0548ae224b
https://doi.org/10.1074/jbc.m602312200
https://doi.org/10.1074/jbc.m602312200
Autor:
Armida W. M. Fabius, Hendrik J. Kuiken, René Bernards, Roderick L. Beijersbergen, Jasper Mullenders, Miranda M.W. van Dongen
Publikováno v:
Molecular cancer research : MCR. 8(4)
The transforming growth factor β (TGFβ) pathway orchestrates an extensive transcriptional program that is important for many processes in the cell. For example, TGFβ regulates cell cycle, migration, and epithelial-to-mesenchymal transition. The TG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3755fb89c33cf1b08fd06e71028d206c
https://pubmed.ncbi.nlm.nih.gov/20332216
https://pubmed.ncbi.nlm.nih.gov/20332216